A Pilot Trial of Sequential Chemotherapy With Antimetabolite Induction, High-Dose Alkylating Agent Consolidation With Peripheral Blood Progenitor Cell Support, and Intensification With Paclitaxel and Doxorubicin for Patients With High-Risk Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Breast Neoplasms
Interventions: DRUG: methotrexate|DRUG: leucovorin|DRUG: 5-fluorouracil|DRUG: cyclophosphamide|PROCEDURE: peripheral blood progenitor cell|DRUG: paclitaxel|DRUG: doxorubicin
Sponsor: National Cancer Institute (NCI)